Cited by 1,018Computational Drug Discovery MethodsArtificial Intelligence in Healthcare and EducationArtificial Intelligence Applications

The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.

Artificial intelligence in drug development: present status and future prospects

Mak, Kit-Kay, Pichika, Mallikarjuna Rao·2019·Drug Discovery Today

DOI 10.1016/j.drudis.2018.11.014

Open this paper in CoChat — free account

Abstract

Artificial intelligence (AI) uses personified knowledge and learns from the solutions it produces to address not only specific but also complex problems. Remarkable improvements in computational power coupled with advancements in AI technology could be utilised to revolutionise the drug development process. At present, the pharmaceutical industry is facing challenges in sustaining their drug development programmes because of increased R&D costs and reduced efficiency. In this review, we discuss the major causes of attrition rates in new drug approvals, the possible ways that AI can improve the efficiency of the drug development process and collaboration of pharmaceutical industry giants with AI-powered drug discovery firms.

Integrity signals

Registry

Crossref · 10.1016/j.drudis.2018.11.014

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Artificial intelligence in healthcare: past, present and future
Jiang, F., Jiang, Y., Zhi, H., Dong, Y., Li, H., Ma, S., Wang, Y., Dong, Q., Shen, H., & Wang, Y. (2017) · Stroke and Vascular Neurology · doi:10.1136/svn-2017-000101 · Cited by 4,837
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Artificial intelligence in medicine
Hamet, P., & Tremblay, J. (2017) · Metabolism · doi:10.1016/j.metabol.2017.01.011 · Cited by 2,334
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
Planning chemical syntheses with deep neural networks and symbolic AI
Segler, M. H. S., Preuss, M., & Waller, M. P. (2018) · Nature · doi:10.1038/nature25978 · Cited by 1,847
The rise of deep learning in drug discovery
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770
Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537
Deep Learning in Medical Imaging: General Overview
Lee, J., Jun, S., Cho, Y.-W., Lee, H., Kim, G. B., Seo, J. B., & Kim, N. (2017) · Korean Journal of Radiology · doi:10.3348/kjr.2017.18.4.570 · Cited by 1,328
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185

Show all 73 references

Sorted by citations

Items 901–1,000 of 1,000

AI strategies for drug discovery and bioactivity prediction: opportunities and challenges
Azad, A. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34059-8.00013-0
HIV Tanı ve Tedavisinde Yapay Zeka: Kapsamlı Bir Derleme
Senel, B., & Beka, H. (2025) · DergiPark (Istanbul University)
Scoping insights into artificial intelligence-driven treatment of diabetes mellitus in clinical practice
Al-Taie, A., Hafida, M., Abdulsattar, M., & Mahmoud, R. E. (2026) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-026-00597-z
Improving drug effectiveness using a second-generation artificial intelligence system based on the constrained-disorder principle to incorporate variability into drug design and administration: a perspective
Hurvits, N., Hollander, A., Israeli, A., Sigawi, T., & Ilan, Y. (2026) · Discover Applied Sciences · doi:10.1007/s42452-026-08372-z
Advances in Pharmaceutical Research and Development through Artificial Intelligence and Machine Learning: A Review
Tiwari, A. K., Rai, K., Kahar, H., Khan, A., Quadiri, R., Lokhande, N., & Pandey, S. (2026) · Asian Journal of Research in Chemistry · doi:10.52711/0974-4150.2026.00006
Innovations in Drug Design: Case Studies from Discovery to Development
Saxena, A. K. (2026) · Springer eBooks · doi:10.1007/978-3-032-12320-6_1
Hybrid Multi-Stage Feature Selection for High-Dimensional Sparse Learning in Drug Activity Prediction
Patel, S., Patel, U., & Nanavati, J. (2025) · International Conference on Intelligent Computing, Information and Control Systems (ICOIICS) · doi:10.1109/icoiics67115.2025.11390390
Intranasal delivery of biotherapeutics utilizing nanocarriers: Advancements in surface engineering, clinical progress and the incorporation of artificial intelligence
Vasandia, A. V., More, M. P., Bhatt, P., Baheti, A., Pawar, A., & Tagalpallewar, A. A. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108179
A Study to Analyze the Role of Green AI in Sustainable Practices of Indian Pharmaceutical Sector
Maharshi, K., Chaudhary, P., Bhadu, S., & Kumar, R. (2026) · Emerald Group Publishing Limited eBooks · doi:10.1108/978-1-80592-212-420261016
Artificial Intelligence: A Modern Approach towards Drug Discovery
Wanode, D. M., & Khedekar, P. B. (2026) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2026.00137
Development of Stepwise Forecasting Experimental Design Methods Based on AI Technologies
Park, K., Jeong, J., Jang, J., & Shin, S. (2024) · Journal of the Korean society for quality management · doi:10.7469/jksqm.2024.52.4.603
Artificial Intelligence for predicting drug-likeness and bioavailability
Rajak, B. K., & Rani, P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44415-9.00011-9
Metaphors of medicine: a literary perspective of the involvement of AI in drug discovery, design, and target precision
Oboli, B., Etaware, P. M., & Egara, O. W. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44415-9.00007-7
AI-driven drug repurposing in precision medicine: Transforming existing therapies into targeted solutions
Iqbal, S., Zheng, X., Hu, S., Pal, D., & Shen, B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44430-2.00009-8
Entre progrès et résistances. L’Université à l’épreuve de l’intelligence artificielle
Aguezzoul, A., & Paché, G. A. (2026) · La Revue des sciences de gestion/La Revue des sciences de gestion, Direction et gestion · doi:10.3917/rsg.337.0011
A Comprehensive Review on Modelling Techniques in Drug Research and Development
Panda, K. C., Kumar, B. V. V. R., Jammula, S., Kumar, H. K. S., & Acharyya, S. (2026) · Applied Drug Research Clinical Trials and Regulatory Affairs · doi:10.2174/0126673371410546251201054257
Future of drug development for the treatment of infections
Haider, S. S., Sarmad, M., & Hao, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36518-8.00013-8
AI integration in bioactive-oriented research: Discovery, development, and design for pharmaceutical and medical applications
Islam, M. T. (2026) · Journal of Phytochemical Insights · doi:10.71193/jpci.20260017
Large language models and generative AI in healthcare: Multimodal intelligence, clinical integration, and the future of medical practice
Gupta, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45252-9.00013-x
TETGen: A Transcriptome-Guided Transformer for Targeted Molecule GenerationPreprint
Gao, J., Cao, Y., Zhou, R., Li, Y., Wang, J., Ding, W., Ma, M., Wu, D., Zhou, Y., Yuan, B., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9234106/v1
Frameworks for the Future: Implementing FDA Guidance on Artificial Intelligence in Biopharma
Vatsavai, K. R., Kamma, J., Ramgiri, A. K., & Hotha, K. K. (2026) · American Journal of Analytical Chemistry · doi:10.4236/ajac.2026.173005
Beyond fragmented strategy choices: a systemic approach to support R&D investment in pharma and biotech companies
Cosenz, F., & Domenico, F. D. (2026) · European Journal of Innovation Management · doi:10.1108/ejim-10-2025-1382 · Cited by 1
A Versatile Single-Cell Analysis Pipeline for High-Content Screening by Live-Cell Imaging
Zyss, D. (2024) · theses.fr (ABES) · doi:10.70675/2b6332a0zeb61z41a6z9e7az03aa623af8b9
Cognition-enhancing drugs: current landscape, mechanisms, and future prospects
Zhang, M., Lin, C., Zhang, W., & Wang, X. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104665
Computational Intelligence for Drug Design and Development
Shukla, K., & Bansal, H. (2026) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-2600-0981-9.ch007
Open R&D in the context of business model transformation: the case of Big Pharma
Abotk, A. (2026) · Strategy and Leadership · doi:10.1108/sl-09-2025-0329
A novel imaging-based multi-sample viscometry application for advancing monoclonal antibody development
Lopez, K. L., Palomba, F., Mock, M. L., Srinivasan, N., Pelegri-O’Day, E. M., & Digman, M. A. (2026) · Methods and Applications in Fluorescence · doi:10.1088/2050-6120/ae5e1a
Harnessing Artificial Intelligence Across The Drug Lifecycle: From Discovery To Optimized Operations
Srinu, K., Chintapalli, G. S., Mishra, K., Surendra, K., & Kumar, M. V. (2026) · European journal of parenteral & pharmaceutical sciences · doi:10.37521/ejpps31108
Harnessing artificial intelligence and machine learning for accelerating drug repurposing in hepatitis B virus therapy
Ugbaja, S. C., Dangana, R. S., Sanusi, I. O., Ibitoye, O. A., Nkungu, A., Mafuleka, L., Okpeku, M., & Gqaleni, N. (2026) · Discover Artificial Intelligence · doi:10.1007/s44163-026-01263-7
Artificial intelligence and antiaging research
Arumugam, S., Muthuvel, R., Antony, B. S., Chandrasekaran, K., & Subbaraj, G. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33159-6.00009-6
Artificial intelligence for drug discovery and development
Mashaqbeh, H., Shakhatreh, G., & Daghmash, R. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27638-5.00014-6
A Review Study on the Discovery & Development of Medicine Using the Machine Learning
Kumar, K., & Saxena, A. (2026) · Lecture notes in networks and systems · doi:10.1007/978-3-032-19182-3_2
AI and the Future of Pharmacy: Innovation, Ethics, and Impact
Mane, R. P., Shendage, P. N., Jadhav, P. S., & Patil, R. A. (2026) · Research Journal of Pharmaceutical Dosage Forms and Technology · doi:10.52711/0975-4377.2026.00021
Introduction of AI in drug design
Huang, S., & Ou, T. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45105-8.00008-1 · Cited by 1
Trends of Open-Source Tools and Frameworks for AI Drug Design
Mishra, S. K., Mukhia, P., Gurung, K., Rai, P., Roy, A., Chhetri, T., & Georrge, J. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-20428-8_11
Novel molecular design via a scaffold-aware transformer with multi-scale attention mechanisms
Park, J., & Yoo, S. (2026) · Journal of Cheminformatics · doi:10.1186/s13321-026-01221-6
Transformer-Type Architecture for Predicting Physicochemical Properties of Cosmetic Emulsions
Solarte, S., Porras, A., Pradilla, D., & Solano, Ó. A. Á. (2026) · ACS Omega · doi:10.1021/acsomega.6c02941
Artificial intelligence for drug discovery and development
Jassica, Bajaj, J. S., Gupta, K., Kaushal, R. K., & Kumar, N. (2026) · AIP conference proceedings · doi:10.1063/5.0335694
Artificial intelligence, ethics, and sustainability: crafting responsible healthcare solutions
Agarwal, N., Kumar, P., & Ye, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33700-0.00010-8
References
Achard, P. O. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815943126010011
Redesigning the Antibiotic Market for Survival: How Artificial Intelligence May Address the Economic Failure in Combating Antimicrobial Resistance
Litta, L. (2026) · Journal for Global Business and Community · doi:10.56020/001c.162422
Convergence and innovative applications of cutting-edge biomedical technologies in brain organoid research
Zhang, Z., Wang, Y., Chen, L., & Ming, D. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115877
AI Applications in Healthcare Education Security And Smart Cities
Khan, M. A., Mundra, A., Kumar, G., Kumar, C. S., & Singh, S. P. (2025) · International Conference on Computational Engineering, Sensing Technology and Management (ICCETM) · doi:10.1109/iccetm66557.2025.11557792
Overview of artificial intelligence-based smart healthcare systems
Taherdoost, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27692-7.00002-2
Artificial Intelligence and Large Language Models in Drug Discovery and Pharmacogenomics: A Comprehensive Pharmacological Review of AlphaFold, Generative AI for De Novo Design, Clinical Decision Support, and the Translational Pipeline
Begum, A., Manisha, D. R. L., & Sudhakar, M. (2026) · International Journal of Research and Review · doi:10.52403/ijrr.20260610
Machine Learning and Virtual Screening Methods to Discover Potential Cyclin-Dependent Kinase 2 (CDK2) Inhibitors
Rampogu, S. D., Balasubramaniyam, T., Kubiak, J. Z., & Lee, K. W. (2026) · Pharmaceuticals · doi:10.3390/ph19071019
Insect derived metabolites in drug discovery: Pharmacological potential, mechanisms, and translational challenges
Vairale, S., & Agawane, S. B. (2026) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2026.100808
Artificial Intelligence in Drug Design: Emerging Trends and Applications
Gupta, J., Jain, S. D., Agrawal, A., & Gupta, A. K. (2026) · International Journal of Newgen Research in Pharmacy & Healthcare · doi:10.61554/ijnrph.v4i1.2026.235
Antiepileptic potential of salicylhydroxamic acid: genomic, molecular docking, and functional evaluations in pentylenetetrazole-induced adult zebrafish
Dheeraja, V. D. C., Aayushi, G., Neniwal, J. P., Gokulan, M. A., Thamaraikani, T., Chitra, V., Narayanan, J., Chinni, S. V., & Gopinath, S. C. B. (2026) · 3 Biotech · doi:10.1007/s13205-026-04910-z
DBG-DDA: A Dual-Branch Graph Learning Method for Drug-Disease Associations Prediction
Guan, Z., Lei, B., Zeng, X., Tang, J., Wang, T., Chen, W., & Yang, L. (2026) · Big Data Mining and Analytics · doi:10.26599/bdma.2025.9020094
From Data Science to Artificial Intelligence
Fogel, G. B. (2026) · Springer eBooks · doi:10.1007/978-3-032-11023-7_1
Emerging trends in artificial intelligence in drug design and development: Revolutionizing clinical practices
Nithya, N. S., Srinivasan, V., Tan, S. C., & Nandhini, G. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45374-8.00024-1
Accelerating Drug Discovery and Development: Harnessing AI for Enhanced Efficiency and Speed
Sajithabanu, S., Ramachandran, M. S., Anand, A. J., & Samundeeswari, K. (2026) · Springer eBooks · doi:10.1007/978-3-032-23626-5_13
Future-Ready Pharmaceutical Sciences and Phytopharmacology: From Molecular Intelligence to Responsible Natural Product-Based Therapeutics
Thompson, D., Mitchell, S., Adams, R., & Brown, J. (2026) · International Journal of Pharmaceutical and Phytopharmacological Research · doi:10.51847/chwxtuymdo
Benchmarking AI for Natural Product Drug Discovery: Data Integrity, Model Robustness, Mechanistic Validity, and Translational Utility
Wright, E., Bennett, C., & Turner, J. (2026) · International Journal of Pharmaceutical and Phytopharmacological Research · doi:10.51847/ipqz02gzus
Regulatory-Ready AI in Pharmaceutical Sciences: An Umbrella Review of Explainability, Reproducibility, Bias, Validation, and Governance Readiness
Kim, D., Park, J., & Kang, M.-S. (2026) · International Journal of Pharmaceutical and Phytopharmacological Research · doi:10.51847/wpeocjwd45
Retrieval-Augmented Phytopharmacology: Connecting Literature Evidence, Molecular Databases, Pathway Knowledge, and Expert Review for Drug Discovery
Williams, N., Collins, G., & Brooks, E. (2026) · International Journal of Pharmaceutical and Phytopharmacological Research · doi:10.51847/txl4jnck8i
Artificial intelligence use among healthcare professionals in healthcare facilities in Lagos, Nigeria: a cross-sectional study
Chima-Oduko, A. A., Maduafokwa, B. A., Abdulraheem, K. S., Roberts, A., Obua, V. C., & Okocha, A. (2026) · BMC Digital Health · doi:10.1186/s44247-026-00291-8 · Cited by 3
Machine Learning (ML) and Deep Learning (DL) Approaches in Multi-target Drug Design
de Menezes, R. P. B., da Silva, P. R., Nobre, T. S., Pontes, A. H. D. O., de Morais, L. F. M., Scotti, L., & Scotti, M. T. (2026) · Royal Society of Chemistry eBooks · doi:10.1039/9781837070206-00519
Machine Learning Applications in Vaccine Design
Parvathy, P. S., Kumar, V. A., Biswas, R., & Mohan, C. G. (2026) · Royal Society of Chemistry eBooks · doi:10.1039/9781837070206-00682
The Pharmacy Profession and the Sustainable Development Goals
Peletidi, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-26472-6.00045-0
New frontiers in organoid research: The synergistic integration of organoids with artificial intelligence
Shekhar, S., Sn, S., Ranjan, A., & Basu, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-43934-6.00024-9
Artificial Intelligence in ADMET Prediction: Transforming Drug Safety and Pharmacokinetic Assessment
Bhuia, M. S. (2026) · Journal of Medicinal Chemistry and Therapeutics · doi:10.71193/jmct.20260013
The Role of Pharmacists in Tackling Mpox: Challenges and Future Prospects: A Narrative Review
Degebo, A. S., Gebretsadik, F. A., Ambaye, A. S., Endalifer, B. L., & Belachew, T. F. (2026) · Health Science Reports · doi:10.1002/hsr2.72916
PredictRx: AI based decision support tool for molecular screening for breast cancer drug recommendation
Chauhan, R., Pandey, N., & Zuhairi, M. F. (2026) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2026.1881187
Artificial Intelligence (AI) Can Accelerate African Development
Ozili, P. K., Obiora, K. I., & Alika, S. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-1474-7.ch013
Knowledge, attitudes, and expectations of undergraduate dental students regarding Artificial Intelligence in prescription writing: a cross-sectional study
Isleyen, M., & Katnik, Y. R. (2026) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1909192
Future Directions and Emerging Technologies
Badal, S. (2026) · Springer eBooks · doi:10.1007/978-3-032-28873-8_12
Artificial intelligence for anticancer drug discovery from natural products of macroalgae and sponges: A systematic review
Rahmaniar, W., Sunarwidhi, A. L., & Hernawan, A. (2026) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2026.109280
The mirage of intelligence: AI fallacies and the fragile foundations of pharma’s future
Pant, P. (2026) · AI and Ethics · doi:10.1007/s43681-026-01301-1
Computational insights into Anacardium occidentale bioactives targeting PBP2a in MRSA infections
Sankaran, S., Fiza, M., Dev, J., Janbeni, M., Mahendra, G. S., Longchar, A., Nishad, J., Venkidasamy, B., Samynathan, R., Goud, P., et al. (2026) · Intelligent Pharmacy · doi:10.1016/j.ipha.2026.08.001
Hybrid artificial intelligence and quantum annealing as an optimization layer in drug discovery
Ou, C., Liao, J.-C., Huang, C., & Lee, O. K. (2026) · Patterns · doi:10.1016/j.patter.2026.101634
The Model Evidence Dossier for Traceable, Adaptive, and Change-Controlled Artificial Intelligence in Pharmaceutical Development
Ramirez, C., Torres, E., Ortega, P., & Mendes, S. (2026) · Pharmacophore · doi:10.51847/2pdevvb1uu
Artificial Intelligence-Enabled Drug Discovery after the Hype Cycle: A Bibliometric and Thematic Review of Twenty-Five Years of Research
Stankova, E., Brown, C., Aisyah, S., & Durand, O. (2025) · Pharmacophore · doi:10.51847/enwqtllm3h
Mapping the Global Technology Landscape and Dynamic Evolution of Artificial Intelligence-assisted Drug R&D Based on Patent Analysis
Wen, J., Yu, X. M., & Yang, W. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10917-z
Strategic Solutions for Overcoming Challenges in AI Adoption
Baig, T., Khan, M. J., & Shehzad, A. (2026) · Springer eBooks · doi:10.1007/978-981-92-0875-3_14
AI Tools for Designing Phytopharmacological Agents
Khan, M. I., & Kim, G. W. (2026) · Springer eBooks · doi:10.1007/978-981-92-0875-3_5
Mitigating antimicrobial resistance in the animal industry: reduction strategies and alternatives to antibiotics
Al-Khalaifah, H. S., & Al-Surrayai, T. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.1912728
Evaluating Artificial Intelligence for Predicting and Interpreting Molecular Toxicity from Chemical Structures to Enhance Early Drug Screening
Samuel, D. N., Ogunlola, J. O., Iwendi, C., Adesola, A. E., Akande, A. O., & Alao-Olatunji, B. A. (2026) · International Conference on Cybersecurity, Digital Forensics, and AI Applications (ICCSDFAI) · doi:10.1109/iccsdfai70505.2026.11648038
From target fishing to AI and single-cell multi-omics: an integrated framework for natural product target research
Du, H., Chen, N., & Sun, Y. (2026) · Targetome · doi:10.48130/targetome-0026-0036
A Knowledge Graph–Driven Multimodal Framework for Drug–Disease Association Prediction
Zhao, Q., Ling, Q., Alamin, M. H., Shu, P., Hong, Y., & Wang, J. (2026) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2026.3724872
Artificial Intelligence-Based Optimization of Pulmonary Drug Delivery Performance in Smart Inhaler Drug–Device Combination Systems
Bhimrao, P. H., Nayak, P. G., Sreedevi, A., Ravi, R., & Muragundi, P. M. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18081026 · Cited by 1
From Marine Peptides to Oncology: The Therapeutic Potential of Conotoxins in Cancer Treatment
Awais, S., Javed, M. A., Ali, R., Shahid, M., Shahid, M. A., Masaud, H., & Ali, N. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.71607
Responsible AI and Data Governance in Pharmaceutical Settings
Sewal, P., Thakur, S., & Kumar, D. (2026) · doi:10.1002/9781394344796.ch18
Regulatory Compliance on Data‐driven Pharmaceutical Research and Development
Akbar, M., Ali, H., Faiyazuddin, M., Sharma, S., Kumar, R., & Sharma, A. (2026) · doi:10.1002/9781394344796.ch17
Artificial intelligence: transforming drug discovery
Mishra, S. (2026) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20263250
Evolution of Libyan Pharmacists’ Perception, Concerns, and Practice of ChatGPT: A Cross-Sectional Study in Libya
Aboulqassim, N. S. S., shennib, A. K., alkremy, M. S., fathallah, L., alhamar, E. M., & almajry, M. A. (2026) · Derna Academy Journal for Applied Sciences · doi:10.71147/bgkxz309
Application of emerging technologies in the antiviral field
Zhang, X., Zhang, L., Guo, T., Du, W., Wang, S., & Li, Y. (2026) · Antiviral Research · doi:10.1016/j.antiviral.2026.106529
Pharmaceutical Innovation as a Co-Evolving System of Excipients, Devices, Data, and Regulation
Müller, A., Weber, S., Hoffmann, J., Schneider, L., & Klein, T. (2025) · Journal of Applied Pharmaceutical Technologies and Systems · doi:10.68159/m407002935
Regulatory Explainability in AI-Assisted Pharmaceutical Formulation and Process Development
Huy, N. T., Minh, P. Q., & Bich, L. T. (2024) · Journal of Applied Pharmaceutical Technologies and Systems · doi:10.68159/b614851200
From Quality-by-Design to Quality-by-Intelligence: Governance of AI-Assisted Pharmaceutical Manufacturing Systems
Turner, M., Nguyen, S., Clark, D., & Wilson, E. (2024) · Journal of Applied Pharmaceutical Technologies and Systems · doi:10.68159/v509528480
Machine learning for alcohol use disorder diagnosis: A systematic review and meta-analysis of prediction models (Preprint)Preprint
Ouyang, J., Huang, L., & Zhou, X. (2026) · doi:10.2196/preprints.111749
Priorities and Implementation Barriers in End-to-End Digital Transformation in the Pharmaceutical Industry: Sequential Mixed Methods Analysis
Rodriguez-Chavez, I. R., Ibrahim, A., Ersezer, B., Radcliffe, A., Gamerman, V., Hartog, B., Iversen, L. F., & Schindler, M. (2026) · Journal of Medical Internet Research · doi:10.2196/91531
Application of Artificial Intelligence in Pharmacy Education: A Scoping Review
Watema-Lord, R., & Sanyal, C. (2026) · Journal of Pharmacy Practice · doi:10.1177/08971900261491254
Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality
Ghonaim, A. H., El-Naka, M. A., Nageeb, W. M., Khan, A. U., Seleem, N. M., Abdelghafar, A., Zamel, D., Liu, Y., He, Q., & Li, W. (2026) · BMEMat · doi:10.1002/bmm2.70133
Decoding the antidiabetic potential of Gymnema sylvestre: An in silico network pharmacology and molecular docking analysis
Raut, S., Gawande, S., lanjekar, R., & Mahabhudhe, J. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100625
Artificial intelligence, network biology and multiomics data in drug discovery
Singh, M., Hafeez, A., Yadav, S. K., Srivastava, U., Singh, P., & Gupta, M. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40338-5.00016-0
Artificial intelligence enabled virtual screening
Kumar, S., & Gupta, M. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40338-5.00010-x
How Generative Artificial Intelligence Stimulates Technological Innovation in Biopharmaceutical Enterprises: Evidence from Chinese A-Share Listed Companies Around the Release of ChatGPT
Tian, Y., Li, N., Li, M., & Li, C. (2026) · Systems · doi:10.3390/systems14101197
Искусственный интеллект в фармации: возможности применения в разработке лекарственных средств
Ахмедова, Ж., & Сабиров, Д. (2026) · Central Asian Journal of Academic Research · doi:10.70413/cajar-v04-i08-s58410

Authors: Mak, K.-K., & Pichika, M. R.
Affiliations: IMU University (MY)
Corresponding author: Pichika, Mallikarjuna Rao
ORCID: Mak, Kit-Kay
Pichika, Mallikarjuna Rao
Venue: Drug Discovery Today
Publisher: Elsevier BV
Published: 2019-03
Volume: 24
Issue: 3
Pages: 773-780
ISSN: 1359-6446 (ISSN-L)
DOI: 10.1016/j.drudis.2018.11.014
OpenAlex: W2901411193
Cited by: 1,018
References: 73
Citations by year: 2026: 161 · 2025: 196 · 2024: 190 · 2023: 170 · 2022: 99 · 2021: 119 · 2020: 63 · 2019: 18
FWCI: 3.94
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Drug Discovery Today (publishedVersion)
PubMed (publishedVersion)
Funders: International Medical University
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Physical Sciences › Computer Science › Artificial Intelligence › Artificial Intelligence Applications
Keywords: artificial intelligence, drug development, drug discovery, attrition rates, research and development costs, pharmaceutical industry
MeSH terms: Artificial Intelligence, Drug Industry, Humans, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Artificial intelligence in drug development: present status and future prospects

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks